Tabla de Contenidos: “…Schwinghammer oChapter 148: Breast Cancer: An Opportunity Lost Level II oChapter 149: Non-Small Cell Lung Cancer: It Takes Your Breath Away Level II oChapter 150: Colon Cancer: Drug Therapy by Design Level II oChapter 151: Prostate Cancer: Missed Opportunity Level II oChapter 152: Non-Hodgkin Lymphoma: Striking Out Cancer Level II oChapter 153: Hodgkin Lymphoma: The Firefighter Level I oChapter 154: Ovarian Cancer: Family Ties Level II oChapter 155: Acute Lymphocytic Leukemia: Ian's Unexpected Weight Loss Level II oChapter 156: Chronic Myelogenous Leukemia: It's Not Always Sunny in Philadelphia Level II oChapter 157: Kidney Cancer: Molecular Therapies Level II oChapter 158: Melanoma: You Have Been Exposed Level II oChapter 159: Hematopoietic Stem Cell Transplantation: Many Meds, Many Interactions Level III *Section 18: Nutrition and Nutritional Disorders Section Editor: Terry L. …”

“…More recently, targeting immune checkpoint molecules have shown therapeutic response against lung cancer and melanoma. Identifying molecules involved in autophagy is another example of how personalized medicine might help treat patients with refractory asthma and autoimmune diseases. …”

“…Articles that focus on a specific type of cancer with known characteristics related to cellular stress responses, for example melanoma or therapy-related cancers are also welcome…”

“…Thus far, inhibitors of CTLA4 and PD-1 have been approved to treat only a limited number of malignancies (e.g. malignant Melanoma, Non-Small Cell Lung Cancer). Many others are currently under investigation and the list of immune checkpoint molecules for potential therapeutic targeting is still growing. …”